large-scale randomized controlled trials of Epithalon have not been published
Expanding on these findings, Kwan et al
Dosage uncertainty: You wont know the active concentration or its bioavailability, which affects both safety and results
What's changed in 2026 is that the regulatory environment requires more specificity from providers about sourcing and compliance, and gives patients better grounds for distinguishing between clinics that are tracking the regulatory picture and those that aren't
The committee is intended to be composed of panelists with scientific expertise across a broad range, including food safety and nutrition, clinical research, veterinary medicine, pharmacology, toxicology, medical devices, and more